Funding Leveraged

More than half of the LRI researchers in the Midwest and nationwide given $300,000 grants to test their innovative hypotheses have such promising findings that they win ongoing funding from the National Institutes of Health (NIH) or other organizations to continue the work.

It’s a stellar return on the investment in lupus discovery.

And it keeps lupus research dollars growing at the NIH, where overall dollars are scarce.

From an LRI Chicago investment of $3 million in lupus research across the Midwest, 7 investigators have gone on to win $13 million more to continue their work—a key part of the larger $70 million that LRI researchers have leveraged nationwide.